SAN CLEMENTE, Calif., April 27, 2007 (PRIME NEWSWIRE) -- We have been notified by NASD that we have been delisted and the companies securities are now being traded pursuant to Pink Sheet listings.
In order to insure that all investors will have access to real time bids and asks on our common stock, we will be contracting with Pink Sheets.com to provide this service.
About Advanced Refractive Technologies, Inc.
Advanced Refractive Technologies, Inc. is an ophthalmology development company focused on the development and marketing of innovative ophthalmic applications that will result in faster, safer and more effective procedures in two of the largest surgical markets in the world: corrective refractive surgery and cataract surgery, as well as innovative drugs for glaucoma and age-related macular degeneration. Advanced Refractive Technologies is currently in the process of developing their Accupulse, a next generation cataract emulsifier, which utilizes the company's proprietary waterjet technology. The Accupulse cataract emulsifier, currently under development, is a device that uses pulsed waterjet technology to remove cataracts -- the most frequently performed surgical procedure in the world. For more information on Advanced Refractive Technologies, please visit its website at http://www.advancedrefractive.com.
The Advanced Refractive Technologies, Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=2498.